MIRROR 2017.

Trial name or title	Efficacy of the Telescopic Mirror Implant for Age‐related Macular Degeneration: The MIRROR Trial
Methods	Parallel‐group, randomized clinical trial
Participants	End‐stage age‐related macular degeneration
Interventions	OriLens device vs. optimized low vision training with the opportunity to try external telescopes
Outcomes	Primary outcome: best‐corrected distance visual acuity, measured using number of letters improvement on ETDRS chart at 12 months Secondary outcomes: best‐corrected distance visual acuity at one, three and six months; best‐corrected near visual acuity, reading speed and contrast sensitivity, measured by MNRead chart and MARS chart at 12 months; vision‐specific quality of life, measured using the IVI at six and 12 months; health‐related quality of life status, measured using the EQ‐5D‐5L questionnaire at six and 12 months; health service use and associated costs, measured by a Health Service Use Questionnaire at six and 12 months
Starting date	2015
Contact information	Dr Catherine Adams The Royal Hospitals Belfast, UK
Notes	Intention to publish date: 28 February 2020